Long-Term Tolerability of the Bisphosphonates in Postmenopausal Osteoporosis: A Comparative Review

Author： Kherani R.B. Papaioannou A. Adachi J.D.

ISSN： 0114-5916

Source： Drug Safety, Vol.25, Iss.11, 2002-01, pp. : 781-790

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of long-term bisphosphonates in postmenopausal osteoporosis

By Miller Paul D

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2253-2258

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Management of Osteoporosis in Postmenopausal Women: A Comparative Review

By Reid I.R.

Drugs & Aging, Vol. 15, Iss. 5, 1999-11 ,pp. : 349-363

Adis International

Access to resources Recommend Favorite

Long-Term Safety of Bisphosphonate Therapy for Osteoporosis: A Review of the Evidence

By Liberman Uri A.

Drugs & Aging, Vol. 23, Iss. 4, 2006-01 ,pp. : 289-298

Adis International

Access to resources Recommend Favorite

Application of a Systems Pharmacology‐Based Placebo Population Model to Analyze Long‐Term Data of Postmenopausal Osteoporosis

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 2163-8306, Iss. 9, 2015-09 ,pp. : 516-526

John Wiley & Sons Inc

Access to resources Recommend Favorite

Application of a Systems Pharmacology‐Based Placebo Population Model to Analyze Long‐Term Data of Postmenopausal Osteoporosis

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 9, 2015-09 ,pp. : 516-526

John Wiley & Sons Inc

Access to resources Recommend Favorite